BPG is committed to discovery and dissemination of knowledge
Articles in Press
2/24/2026 8:34:08 AM | Browse: 3 | Download: 0
Publication Name World Journal of Stem Cells
Manuscript ID 116280
Country China
Category Cell & Tissue Engineering
Manuscript Type Basic Study
Article Title Erythropoietin-overexpressing mesenchymal stem cells accelerate diabetic wound healing via steroid signaling pathway modulation
Manuscript Source Unsolicited Manuscript
All Author List Bao-Dong Ma, Shu-Juan Zhang, Yi-Ming Shao, Ran-Ran Jin, Lei Sun, Peng-Ju Lv, Han Yue, Shou-Kui Hu and Xi-Wen Ma
Funding Agency and Grant Number
Funding Agency Grant Number
Science and Technology Project of Henan Province 242102310112, LHGJ20230786
Incubation Project of Advanced Medical Research Center XJYXZX2021007
Corresponding Author Xi-Wen Ma, MD, Professor, Department of Geriatric, Zhengzhou Central Hospital Affiliated to Zhengzhou University, No. 16 Tongbai North Road, Zhongyuan District, Zhengzhou 450007, Henan Province, China. maxiwen@zzu.edu.cn
Key Words Diabetic wound healing; Erythropoietin; Mesenchymal stem cells; Proteomics; Single-cell RNA sequencing; Transcriptomics
Core Tip This study shows that erythropoietin-overexpressing mesenchymal stem cells (EPO-MSCs) accelerate diabetic wound repair by enhancing fibroblast migration, angiogenesis, and macrophage polarization. Integrated transcriptomic, proteomic, and single-cell analyses identify serum amyloid A3-positive reparative macrophages and C-C motif chemokine ligand-centered macrophage-neutrophil crosstalk as key immune nodes modulated by EPO-MSCs, alongside changes in steroid-related pathways. These mechanistic insights suggest that gene-engineered mesenchymal stem cells can overcome the chronic inflammatory microenvironment of diabetic wounds and provide a rationale for future dose optimization, safety evaluation, and early-phase clinical trials of EPO-MSCs therapy.
Citation Ma BD, Zhang SJ, Shao YM, Jin RR, Sun L, Lv PJ, Yue H, Hu SK, Ma XW. Erythropoietin-overexpressing mesenchymal stem cells accelerate diabetic wound healing via steroid signaling pathway modulation. World J Stem Cells 2026; In press
Received
2025-11-07 09:55
Peer-Review Started
2025-11-07 09:56
First Decision by Editorial Office Director
2025-11-21 07:06
Return for Revision
2025-11-21 07:06
Revised
2025-12-01 04:19
Publication Fee Transferred
2025-12-02 10:30
Second Decision by Editor
2026-02-13 02:40
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-02-24 08:34
Articles in Press
2026-02-24 08:34
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1948-0210 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com